Press Releases
ProBioGen in Biosimilar Deal with Bio Farma Indonesia
read more ProBioGen in Biosimilar Deal with Bio Farma Indonesia
Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development
read more Zymeworks Contracts ProBioGen for Bi-specific GlymaxX® Antibody Cell Line Development
20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion
read more 20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion
ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis
read more ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis
ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology
read more ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology